Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.87%87.97M | -31.52%285.99M | -12.63%76.58M | -39.12%60.28M | -37.41%69.06M | -33.60%80.07M | 11.07%417.6M | -14.17%87.65M | 2.41%99.01M | 15.76%110.35M |
| Cost of revenue | 6.39%80.1M | -38.30%252.65M | -24.65%62.36M | -42.90%54.47M | -47.29%59.72M | -36.22%75.29M | 10.80%409.5M | -22.25%82.76M | 3.34%95.4M | 28.51%113.29M |
| Gross profit | 64.64%7.87M | 311.42%33.34M | 190.62%14.22M | 60.63%5.81M | 417.86%9.35M | 87.49%4.78M | 26.71%8.1M | 213.37%4.89M | -17.33%3.62M | -140.98%-2.94M |
| Operating expense | 46.77%4.61M | 17.02%21.28M | -9.76%9.89M | 7.72%4.12M | 36.25%5.76M | -15.35%3.14M | 22.22%18.18M | 160.80%10.96M | 50.31%3.82M | -6.60%4.23M |
| Selling and administrative expenses | 18.77%4.87M | 11.44%22.82M | -9.76%9.89M | -0.32%4.41M | 7.80%5.9M | 3.46%4.1M | 2.88%20.48M | 96.21%10.96M | -3.30%4.42M | 7.29%5.48M |
| -General and administrative expense | 18.77%4.87M | 11.44%22.82M | -9.76%9.89M | -0.32%4.41M | 7.80%5.9M | 3.46%4.1M | 2.88%20.48M | 96.21%10.96M | -3.30%4.42M | 7.29%5.48M |
| Total other operating income | -73.56%252K | -32.81%1.54M | ---- | -51.24%294K | -88.69%141K | 287.40%953K | -54.35%2.3M | -85.62%199K | -70.34%603K | 116.49%1.25M |
| Operating profit | 98.96%3.26M | 219.65%12.06M | 171.26%4.33M | 930.39%1.69M | 149.98%3.58M | 240.55%1.64M | -18.84%-10.08M | 28.74%-6.07M | -111.13%-204K | -370.94%-7.17M |
| Net non-operating interest income (expenses) | -1.67%-1.28M | 6.73%-4.85M | -28.56%-1.86M | -10.21%-1.45M | -0.77%-1.31M | -10.52%-1.26M | -31.91%-5.2M | -56.66%-1.45M | -41.08%-1.31M | -43.33%-1.3M |
| Non-operating interest income | -69.34%168K | 34.04%1.64M | -2.33%336K | 18.21%370K | 42.65%388K | 85.14%548K | 75.25%1.23M | 33.85%344K | 34.91%313K | 147.27%272K |
| Non-operating interest expense | -19.85%1.45M | 1.04%6.49M | 22.63%2.2M | 11.75%1.82M | 8.02%1.7M | 25.89%1.81M | 47.84%6.43M | 102.26%1.79M | 39.85%1.63M | 54.57%1.57M |
| Net investment income | 32.33%-90K | -469.13%-2.5M | -126.57%-283K | -1,035.29%-193K | -133.33%-1.89M | -130.23%-133K | 677K | 1.07M | -105.17%-17K | 60.79%-810K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 3.66%-4.18M | -389.53%-4.34M | ||||||||
| Less:Write off | ---- | -3.66%4.18M | ---- | ---- | ---- | ---- | 389.53%4.34M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -32.42%1.55M | 134.10%163K | 2.3M | -478K | ||||||
| Income before tax | 678.10%1.88M | 115.42%3.03M | 133.87%2.35M | 103.59%55K | 104.13%383K | 112.98%242K | -79.64%-19.62M | 16.62%-6.93M | -224.43%-1.53M | -2,737.61%-9.28M |
| Income tax | 1,023.08%584K | -67.75%1.78M | -45.47%1.22M | -79.02%257K | -68.65%263K | -96.08%52K | 16.30%5.53M | 224.96%2.24M | -15.46%1.23M | -35.86%839K |
| Net income | 583.68%1.3M | 104.94%1.24M | 112.28%1.13M | 92.68%-202K | 101.19%120K | 105.95%190K | -60.42%-25.15M | -1.88%-9.17M | -1,170.97%-2.76M | -518.84%-10.12M |
| Net income continuous operations | 583.68%1.3M | 104.94%1.24M | 112.28%1.13M | 92.68%-202K | 101.19%120K | 105.95%190K | -60.42%-25.15M | -1.88%-9.17M | -1,170.97%-2.76M | -518.84%-10.12M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 583.68%1.3M | 104.94%1.24M | 112.28%1.13M | 92.68%-202K | 101.19%120K | 105.95%190K | -60.42%-25.15M | -1.88%-9.17M | -1,170.97%-2.76M | -518.84%-10.12M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 583.68%1.3M | 104.94%1.24M | 112.28%1.13M | 92.68%-202K | 101.19%120K | 105.95%190K | -60.42%-25.15M | -1.88%-9.17M | -1,170.97%-2.76M | -518.84%-10.12M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 800.00%0.0009 | 105.08%0.0009 | 112.31%0.0008 | 94.74%-0.0001 | 101.41%0.0001 | 104.35%0.0001 | -59.46%-0.0177 | -1.56%-0.0065 | -850.00%-0.0019 | -491.67%-0.0071 |
| Diluted earnings per share | 800.00%0.0009 | 105.08%0.0009 | 112.31%0.0008 | 94.74%-0.0001 | 101.41%0.0001 | 104.35%0.0001 | -59.46%-0.0177 | -1.56%-0.0065 | -850.00%-0.0019 | -491.67%-0.0071 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.